BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 18, 2012
View Archived Issues
Multiple insulin degludec trials presented at recent conferences
Read More
Canadian study links gene's copy number to ankylosing spondylitis
Read More
New model allows assessment of two islet preparations in one primate
Read More
Novel apoptosis inducers created at IMPACT Therapeutics
Read More
First-in-human data presented on oncolytic BAY-1000394
Read More
Simcere presents new calcium channel blockers/acetylcholinesterase inhibitors
Read More
Eli Lilly designs novel metabotropic glutamate receptor antagonists
Read More
Sunovion reports Canadian approval of once-daily schizophrenia therapy
Read More
Anergis achieves preclinical milestones
Read More
Civitas Therapeutics advances inhaled levodopa formulation to phase IIa
Read More
Sublingual drug for sleep disorders approved in Europe
Read More
AstraZeneca and Dainippon Sumitomo jointly patent new oncolytics
Read More
New tau-detecting diagnostics developed by GE Healthcare and Medi-Physics
Read More
Portola updates on trial of universal factor Xa inhibitor antidote
Read More
Phase II study tests iron chelator in adults with transfusional iron overload
Read More
EPFL reports novel antibacterials
Read More
Dyax discontinues trial of drug for ACE inhibitor-induced angioedema
Read More
Wilex oral uPA inhibitor is efficacious in proof-of-concept study
Read More
Lysogene advances gene therapy study in Sanfilippo type A syndrome
Read More
Janssen files applications to extend Zytiga indication
Read More
Debiopharm and Ascepion enter license agreement for multikinase inhibitor
Read More
Bavarian Nordic receives government contract for MVA-BN-based vaccines
Read More
Valeant Pharmaceuticals to acquire oral health product company
Read More
Tosedostat studied for elderly patients with AML or high-risk MDS
Read More
First clinical data disclosed on Bristol-Myers Squibb drug for cancer
Read More